Literature DB >> 17005155

Calpain-resistant fragment(s) of alpha-synuclein regulates the synuclein-cleaving activity of 20S proteasome.

Hyun Jin Kim1, Daekyun Lee, Choong-Hwan Lee, Kwang Chul Chung, Jongsun Kim, Seung R Paik.   

Abstract

Alpha-synuclein is a pathological component of Parkinson's disease by participating in Lewy body formation. Imbalance in protein turnover could result in the abnormal protein aggregation responsible for eventual neuronal cell death. This in vitro digestion study showed that both m-calpain and 20S proteasome preferentially hydrolyzed the N-terminal half of alpha-synuclein, which made the hydrophobic NAC and following acidic C-terminal region resistant against the proteolyses. Since the acidic C-terminal region contains the PEST segment-a protein degradation signal enriched with amino acids of proline (P), glutamate (E), serine (S), and threonine (T)-, the PEST segment has not been processed or even required for the proteolyses. Alpha-synuclein would be recognized primarily by m-calpain since the common substrate was processed by m-calpain five times more effectively than 20S proteasome with k(cat)/K(m) of 1.64 x 10(4)M(-1)s(-1) and 0.32 x 10(4) M(-1)s(-1), respectively. The N-terminally truncated protease-resistant C-terminal fragment of alpha-syn61-140 was demonstrated to stimulate the 20S proteasome-mediated breakdown of alpha-synuclein and its mutant forms of Ala53Thr and Ala30Pro. The stimulation for Ala53Thr, however, was noticeably less efficient than those for the other proteins, which might support the previous observation of the prolonged intracellular life span of Ala53Thr by 1.5-fold compared to that of wild-type form. We have hypothesized that the N-terminally truncated C-terminal fragment derived from the abundant alpha-synuclein through intracellular proteolyses could be involved in various physiological or pathological effects which might be related to the formation of abnormal protein aggregation and subsequent neuronal degeneration by influencing the intracellular protein turnover or directly participating in the aggregate formation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17005155     DOI: 10.1016/j.abb.2006.08.019

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  7 in total

Review 1.  The Role of Extracellular Matrix Components in the Spreading of Pathological Protein Aggregates.

Authors:  Edoardo Moretto; Skye Stuart; Sunaina Surana; Jose Norberto S Vargas; Giampietro Schiavo
Journal:  Front Cell Neurosci       Date:  2022-04-29       Impact factor: 6.147

Review 2.  A critical evaluation of the ubiquitin-proteasome system in Parkinson's disease.

Authors:  Casey Cook; Leonard Petrucelli
Journal:  Biochim Biophys Acta       Date:  2009-02-03

Review 3.  Protein truncation as a common denominator of human neurodegenerative foldopathies.

Authors:  Santosh Jadhav; Norbert Zilka; Michal Novak
Journal:  Mol Neurobiol       Date:  2013-03-21       Impact factor: 5.590

Review 4.  Protein Transmission, Seeding and Degradation: Key Steps for α-Synuclein Prion-Like Propagation.

Authors:  Abid Oueslati; Methodios Ximerakis; Kostas Vekrellis
Journal:  Exp Neurobiol       Date:  2014-12-12       Impact factor: 3.261

Review 5.  Proteolytic α-Synuclein Cleavage in Health and Disease.

Authors:  Alexandra Bluhm; Sarah Schrempel; Stephan von Hörsten; Anja Schulze; Steffen Roßner
Journal:  Int J Mol Sci       Date:  2021-05-21       Impact factor: 5.923

6.  alpha-Synuclein and neuronal cell death.

Authors:  Mark R Cookson
Journal:  Mol Neurodegener       Date:  2009-02-04       Impact factor: 14.195

7.  A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathies.

Authors:  Maike Hartlage-Rübsamen; Alexandra Bluhm; Sandra Moceri; Lisa Machner; Janett Köppen; Mathias Schenk; Isabel Hilbrich; Max Holzer; Martin Weidenfeller; Franziska Richter; Roland Coras; Geidy E Serrano; Thomas G Beach; Stephan Schilling; Stephan von Hörsten; Wei Xiang; Anja Schulze; Steffen Roßner
Journal:  Acta Neuropathol       Date:  2021-07-26       Impact factor: 17.088

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.